Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 16.16 is 220% above its 5-year average of 5.05, near the high end of its 5-year range (0.92–19.81).
As of the fiscal period ended Tuesday, June 30, 2026. 36.08% above its 12-month average of 11.88.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.16.
CURRENT RATIO
16.16
CURRENT RATIO AVG TTM
11.88
CURRENT RATIO AVG 3Y
4.66
CURRENT RATIO AVG 5Y
5.05
CURRENT RATIO AVG 10Y
8.18
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+36.08%
CURRENT VS 3Y AVG
+247.10%
CURRENT VS 5Y AVG
+220.21%
CURRENT VS 10Y AVG
+97.62%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 595 covered companies
CURRENT VS SECTOR MEDIAN
+375.35%
vs the sector median at left
Corvus Pharmaceuticals, Inc.
Market Cap
$865.29M
Current Ratio
16.16
TTM Avg
11.88
3Y Avg
4.66
5Y Avg
5.05
Market Cap
$882.16M
Current Ratio
81.42
TTM Avg
11.94
3Y Avg
8.59
5Y Avg
10.34
Market Cap
$843.53M
Current Ratio
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
Market Cap
$817.92M
Current Ratio
14.93
TTM Avg
20.63
3Y Avg
16.30
5Y Avg
22.70
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $865.29M | 16.16 | 11.88 | 4.66 | 5.05 |
| Arbutus Biopharma Corp (ABUS)vs › | $882.16M | 81.42 | 11.94 | 8.59 | 10.34 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $843.53M | 9.52 | 4.26 | 6.09 | 7.80 |
| Bioventus Inc. (BVS)vs › | $890.64M | 1.69 | 1.50 | 1.36 | 1.44 |
| Beta Bionics, Inc. (BBNX)vs › | $835.01M | 8.88 | 7.47 | 6.98 | 6.98 |
| Alumis Inc. (ALMS)vs › | $825.62M | 6.74 | 5.17 | 5.15 | 5.15 |
| Apnimed, Inc. (APMD)vs › | $818.83M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $817.92M | 14.93 | 20.63 | 16.30 | 22.70 |
| HealthStream, Inc. (HSTM)vs › | $917.50M | 1.06 | 1.14 | 1.09 | 1.06 |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | 3.34 | 4.45 | 4.03 | 4.25 |
Current Ratio
16.16
Quick Ratio
16.16
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 16.16 |
| 2026-03-31 | 19.81 |
| 2025-12-31 | 6.21 |
| 2025-09-30 | 8.29 |
| 2025-06-30 | 8.91 |
| 2025-03-31 | 4.90 |
| 2024-12-31 | 1.54 |
| 2024-09-30 | 0.92 |
| 2024-06-30 | 3.62 |
| 2024-03-31 | 3.40 |
| 2023-12-31 | 4.07 |
| 2023-09-30 | 4.53 |
| 2023-06-30 | 4.82 |
| 2023-03-31 | 4.29 |
| 2022-12-31 | 4.06 |
| 2022-09-30 | 3.67 |
| 2022-06-30 | 5.80 |
| 2022-03-31 | 6.95 |
| 2021-12-31 | 7.36 |
| 2021-09-30 | 6.97 |
| 2021-06-30 | 5.59 |
| 2021-03-31 | 4.94 |
| 2020-12-31 | 3.73 |
| 2020-09-30 | 4.38 |
| 2020-06-30 | 5.24 |
| 2020-03-31 | 5.96 |
| 2019-12-31 | 7.76 |
| 2019-09-30 | 9.97 |
| 2019-06-30 | 9.17 |
| 2019-03-31 | 12.39 |
| 2018-12-31 | 14.51 |
| 2018-09-30 | 16.07 |
| 2018-06-30 | 13.75 |
| 2018-03-31 | 13.69 |
| 2017-12-31 | 9.06 |
| 2017-09-30 | 10.11 |
| 2017-06-30 | 11.73 |
| 2017-03-31 | 16.24 |
| 2016-12-31 | 18.36 |
| 2016-09-30 | 26.10 |
| 2016-06-30 | 42.55 |
| 2016-03-31 | 45.54 |
| 2015-12-31 | 31.16 |
| 2015-09-30 | 111.05 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 4.69 |
